Guilin Tang
The University of Texas MD Anderson Cancer Center · Houston, United States
Is this your team? Claim it
Latest publication · Cancer, Oct 2026Outcomes of adult patients with Li-Fraumeni syndrome and myeloid neoplasms.
Research view
Switch to patient viewAcute lymphoblastic leukaemia: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target or a country to narrow the list.
- All targets
- CD19 122
- CD22 33
- ABL1 10
- KMT2A 8
- CD20 8
- TP53 0
- AKT 0
- BCL-2 3
- PI3K 0
- CD123 5
- JAK 2
- CD38 4
- PD-1 3
- RUNX1 0
- mTOR 0
- NPM1 4
- BCMA 4
- NOTCH1 0
- CXCR4 1
- PTEN 0
- CTNNB1 0
- EGFR 0
- HDAC 0
- IDH 0
- MYC 0
- RAS 0
- STAT3 0
- AMPK 0
- CD30 0
- CD40 0
- CD47 0
- ERK 0
- FGFR 0
- MAPK 0
- MDM2 0
- PD-L1 0
- CD33 1
- FLT3 0
- IL-1 0
- IL-17 0
- IL-6 0
- KRAS 0
- MEK 0
- PPAR 0
- RANKL 0
- RB1 0
- TYK2 0
- ALK 0
- AXL 0
- BRCA1 0
- BRD4 0
- BTK 0
- CDK4/6 0
- CDKN2A 0
- CTLA-4 0
- EZH2 0
- FAK 0
- FTO 0
- GPRC5D 1
- GPX4 0
Institute of Hematology & Blood Diseases Hospital
Tianjin, China
Publications on this disease47
Medical College of Wisconsin
Milwaukee, United States
Publications on this disease23
Wuhan Union Hospital
Wuhan, China
Publications on this disease14
Nationwide Children's Hospital
Columbus, United States
Publications on this disease13
5 of 5+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
NIH NCI · F31
Overcoming CD4 T Cell Dysfunction in Acute Lymphoblastic Leukemia
NIH NCI · R41
Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia
NIH NCI · R34
NIH NCI · R01
NIH NCI · R43
European Commission (Horizon Europe) · HORIZON-ERC-POC
SMART-SMAPs: a new paradigm of cell-free cytotoxic immunotherapy for resistant CLL
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-RIA
European Commission (Horizon Europe) · HORIZON-RIA
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Role of RAS mutant subclones in the development of High Hyperdiploid B-ALL (RasWayToALL)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-CSA
Science, Innovation, Health, Earth, And Life Technologies for ALL (SCIENCE4ALL)
10 of 294 running projects, newest first. Listed amounts together: US$164.5m + €62.2m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"
“Following the recommendation of the Data Monitoring Committee (DMC), based on the results of the interim analysis, the Sponsor has decided to terminate the study prematurely”Registry text, quoted unchanged. Source
Terminated
CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL
“Low accrual”Registry text, quoted unchanged. Source
Terminated
“Achieve the proof of concept”Registry text, quoted unchanged. Source
Terminated
“Sponsor's Research and Development strategy adjustment”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 6
- Mendelian Randomization Analysis 4
- CRISPR-Cas Systems 5
- Gene Expression Profiling 27
- Sequence Analysis, RNA 2
- Whole Genome Sequencing 1
- Exome Sequencing 1
- Proteomics 7
- Metabolomics 4
- Flow Cytometry 40
- Immunohistochemistry 6
- Circulating Tumor DNA 1
- Xenograft Model Antitumor Assays 50
- Magnetic Resonance Imaging 14
- Machine Learning 11
- Deep Learning 8
- Cohort Studies 26
- Genome-Wide Association Study 8
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.